Page last updated: 2024-10-29

ketanserin and Apoplexy

ketanserin has been researched along with Apoplexy in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Stroke was significantly delayed in rats with high BRS than those with low BRS (time to 50% death was 1."1.34Arterial baroreflex: a novel target for preventing stroke in rat hypertension. ( Chen, H; Liu, AJ; Liu, JG; Ma, XJ; Shen, FM; Su, DF, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, AJ1
Ma, XJ1
Shen, FM1
Liu, JG1
Chen, H1
Su, DF1

Other Studies

1 other study available for ketanserin and Apoplexy

ArticleYear
Arterial baroreflex: a novel target for preventing stroke in rat hypertension.
    Stroke, 2007, Volume: 38, Issue:6

    Topics: Animals; Baroreflex; Blood Pressure; Drug Delivery Systems; Female; Hypertension; Ketanserin; Male;

2007